What is the recommended treatment for gonorrhea, including dosing and alternatives for pregnancy, cephalosporin allergy, and suspected cephalosporin resistance?

Treatment for Gonorrhea

The recommended first-line treatment for uncomplicated gonorrhea is ceftriaxone 500 mg intramuscularly as a single dose, plus doxycycline 100 mg orally twice daily for 7 days if chlamydial coinfection has not been excluded. 1, 2

Standard Treatment Regimen

The current CDC guidelines prioritize ceftriaxone monotherapy at 500 mg IM (increased from the previous 250 mg dose) based on stable ceftriaxone resistance patterns in the United States and rising azithromycin resistance 1, 2. This represents a shift from the 2015 dual therapy recommendation that included azithromycin 1 g, which was abandoned due to antimicrobial stewardship concerns and the rapid rise in azithromycin resistance (nearly 5% of isolates by 2018) 2.

Key dosing points:

• Ceftriaxone 500 mg IM once - effective for urogenital, anorectal, AND pharyngeal gonorrhea 1
• Add doxycycline 100 mg PO twice daily for 7 days if chlamydia not ruled out (40% coinfection rate) 3, 2
• Medications should be administered on-site when possible to ensure compliance 4

Pregnancy Considerations

Pregnant women should receive ceftriaxone 500 mg IM once, plus azithromycin 1 g orally once (NOT doxycycline). 5

Doxycycline, quinolones, and tetracyclines are absolutely contraindicated in pregnancy 5, 6, 5. Alternative options for chlamydial coinfection include:

• Azithromycin 1 g orally once (preferred)
• Amoxicillin 500 mg orally three times daily for 7 days 5
• Erythromycin base 500 mg four times daily for 7 days 6

Ceftriaxone and spectinomycin have demonstrated 95% efficacy in pregnant women with excellent safety profiles 3. Pregnant women should be retested in the third trimester unless recently treated 7.

Cephalosporin Allergy

For patients with severe cephalosporin allergy, consult an infectious disease specialist immediately, as there are NO universally recommended alternative regimens, particularly for pharyngeal infections. 5, 2

The evidence for alternatives is extremely limited:

Possible options (with significant caveats):

• Azithromycin 2 g orally once - effective but NOT recommended for widespread use due to resistance concerns; requires test-of-cure at 1 week 8
• Gentamicin 240 mg IM once plus azithromycin 2 g orally once - recommended for treatment failures but has poor pharyngeal efficacy (only 20% cure rate in one study) 9
• Spectinomycin 2 g IM once - NOT available in the United States; only 52% effective for pharyngeal infections 6, 5

Critical pitfall: Most alternative regimens fail for pharyngeal gonorrhea, which represents the majority of cephalosporin treatment failures 9. The pharynx serves as a reservoir for transmission and resistance development.

Important note on penicillin allergy: True cross-reactivity between penicillins and cephalosporins is minimal. Patients reporting non-anaphylactic penicillin allergies can safely receive cephalosporins 10. Only severe IgE-mediated reactions (anaphylaxis, Stevens-Johnson syndrome) warrant avoiding cephalosporins entirely.

Suspected Cephalosporin Resistance or Treatment Failure

If treatment failure is suspected (persistent symptoms after standard therapy), immediately:

1. Obtain culture and antimicrobial susceptibility testing
2. Report to local public health within 24 hours
3. Consult infectious disease specialist
4. Treat with gentamicin 240 mg IM once plus azithromycin 2 g orally once 9, 2

Alternative regimens for confirmed resistance include:

• Ertapenem 1 g IM daily for 3 days (requires specialist consultation) 9
• Ceftriaxone 1-2 g IV/IM daily for 3 days 9

Critical caveat: Most "treatment failures" are actually reinfections rather than true resistance 6, 11. However, ceftriaxone MICs remain stable in the U.S. with <0.1% showing alert values (>0.25 mcg/mL) 2.

Site-Specific Considerations

Pharyngeal infections require special attention:

• Pharyngeal gonorrhea is frequently asymptomatic but serves as a transmission reservoir 9
• Ceftriaxone 500 mg IM remains highly effective (unlike gentamicin or spectinomycin) 9, 12
• Oral cefixime shows poor pharyngeal efficacy - one recent trial showed 100% urogenital/rectal cure but multiple pharyngeal failures 12

Gonococcal conjunctivitis:

• Adults: Ceftriaxone 1 g IM once, plus saline lavage 6, 11
• Neonates: Ceftriaxone 25-50 mg/kg IV/IM once (max 250 mg) 5

Follow-Up and Retesting

• No test-of-cure needed for uncomplicated infections treated with recommended regimens 6, 7
• Retest at 3 months - reinfection occurs frequently and indicates need for partner treatment 5, 7
• Test-of-cure at 1 week required if using alternative regimens (cefixime, azithromycin monotherapy) 8

Partner Management

All sexual partners within 60 days before symptom onset or diagnosis must be evaluated and treated, even if asymptomatic 6, 11. Patients should abstain from sexual activity until both they and partners complete treatment and are symptom-free.